387291001: Clioquinol (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antifungal\Clioquinol (substance)
\Substance categorized by disposition\Antiprotozoal\Clioquinol (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antifungal\Clioquinol (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antiprotozoal\Clioquinol (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Quinoline\Substance with oxyquinoline structure (substance)\Clioquinol (substance)

\Diagnostic substance (substance)\Patch test substance\Extended series patch test substance\...

\Medicament patch test substance\Clioquinol (substance)

\Cosmetic series patch test substance\Clioquinol (substance)

\Antimicrobial preservatives patch test substance\Clioquinol (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Substance with oxyquinoline structure (substance)\Clioquinol (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Substance with oxyquinoline structure (substance)\Clioquinol (substance)
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Substance with oxyquinoline structure (substance)\Clioquinol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Clioquinol (substance)	Is a	Antiprotozoal	true	Inferred relationship	Some
Clioquinol (substance)	Is a	Oxyquinoline	false	Inferred relationship	Some
Clioquinol (substance)	Is a	Hydroxyquinoline with antiprotozoal mechanism of action	false	Inferred relationship	Some
Clioquinol (substance)	Is a	Medicament patch test substance	true	Inferred relationship	Some
Clioquinol (substance)	Is a	Antimicrobial preservatives patch test substance	true	Inferred relationship	Some
Clioquinol (substance)	Is a	Cosmetic series patch test substance	true	Inferred relationship	Some
Clioquinol (substance)	Is a	Skin antifungal agent	false	Inferred relationship	Some
Clioquinol (substance)	Is a	Antifungal	true	Inferred relationship	Some
Clioquinol (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiprotozoal	true	Inferred relationship	Some
Clioquinol (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antifungal	true	Inferred relationship	Some
Clioquinol (substance)	Is a	Substance with oxyquinoline structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Clioquinol adverse reaction	Causative agent (attribute)	True	Clioquinol (substance)	Inferred relationship	Some	1
Allergy to clioquinol (finding)	Causative agent (attribute)	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol+hydrocortisone 3%/0.5% cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol+hydrocortisone 3%/1% cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol+hydrocortisone 3%/1% ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol + hydrocortisone 3%ww/0.5%ww cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol + hydrocortisone 3%ww/0.5%ww lotion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol + hydrocortisone 30mg/10mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing clioquinol and hydrocortisone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol+flumethasone pivalate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing ascorbic acid and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol + hydrocortisone + pramoxine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Fluocinolone acetonide+clioquinol 0.025%/3% cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Fluocinolone acetonide+clioquinol 0.025%/3% ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing betamethasone and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
5-Chloro-7-iodo-quinolinol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Product containing calamine and clioquinol and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing clioquinol and flumetasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing clioquinol and fluocinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing clioquinol in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clioquinol (substance)	Inferred relationship	Some
Allergy to clioquinol (finding)	Causative agent (attribute)	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clioquinol (substance)	Inferred relationship	Some	2
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Clioquinol (substance)	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clioquinol (substance)	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing clioquinol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing clioquinol and hydrocortisone in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing clioquinol and flumetasone in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Calamine and clioquinol and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol and flumetasone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing only clioquinol and fluocinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol and hydrocortisone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing only betamethasone and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Product containing only ascorbic acid and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol and flumetasone only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol and hydrocortisone only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing only clioquinol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing only clioquinol in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Betamethasone and clioquinol only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	2
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	1
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing only clioquinol and fluocinolone in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clioquinol (substance)	Inferred relationship	Some	1
Product containing clioquinol and fluocinolone in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Clioquinol (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461469016	Clioquinol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481392014	Clioquinol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491975012	Cloquinol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491976013	Iodochlorhydroxyquin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2164915014	Chloroiodoquine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core